Arunkumar Mohan
Overview
Explore the profile of Arunkumar Mohan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siddappa T, Ravish A, Xi Z, Mohan A, Girimanchanaika S, Krishnamurthy N, et al.
ACS Omega
. 2025 Jan;
10(1):114-126.
PMID: 39829533
STAT3 has emerged as a validated target in cancer, being functionally associated with breast cancer (BC) development, growth, resistance to chemotherapy, metastasis, and evasion of immune surveillance. Previously, a series...
2.
Yang M, Basappa B, Deveshegowda S, Ravish A, Mohan A, Nagaraja O, et al.
J Adv Res
. 2024 Jul;
PMID: 39067696
Introduction: Globally, colorectal cancer (CRC) is the third most common type of cancer, and its treatment frequently includes the utilization of drugs based on antibodies and small molecules. The development...
3.
Parameshwaraiah S, Shivakumar R, Xi Z, Siddappa T, Ravish A, Mohan A, et al.
Chem Biodivers
. 2024 Jan;
21(3):e202301950.
PMID: 38258537
The increased expression of VEGFR-2 in a variety of cancer cells promotes a cascade of cellular responses that improve cell survival, growth, and proliferation. Heterocycles are common structural elements in...
4.
Ravish A, Narasimhachar B, Xi Z, Vishwanath D, Mohan A, Gaonkar S, et al.
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893090
Nuclear factor kappa B (NF-κB) is a potential therapeutic target in breast cancer. In the current study, a new class of oxazine- and piperazine-linked pyrimidines was developed as inhibitors of...
5.
Vishwanath D, Xi Z, Ravish A, Mohan A, Basappa S, Krishnamurthy N, et al.
Molecules
. 2023 Jul;
28(13).
PMID: 37446915
Histone deacetylases (HDACs) are an attractive drug target for the treatment of human breast cancer (BC), and therefore, HDAC inhibitors (HDACis) are being used in preclinical and clinical studies. The...
6.
Venugopal V, Mohan A, Chennabasappa L
Asia Pac Psychiatry
. 2020 Aug;
14(2):e12412.
PMID: 32830876
The COVID-19 is an international public health emergency and threatens psychological resilience. Here we assess the general health status of the public in India during the COVID-19 outbreak. A population-based...